Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Regulation of the G2M cell cycle progression by the ERK5NFB signaling pathway
Kelly Cude1,
Yupeng Wang2,
Hyun-Jung Choi2,
Shih-Ling Hsuan2,
Honglai Zhang3,
Cun-Yu Wang3, , and
Zhengui Xia1,2
1 Graduate Program in Molecular and Cellular Biology and 2 Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195 3 Department of Biologic and Materials Sciences, University of Michigan, Ann Arbor, MI 48109
Correspondence to Zhengui Xia: zxia{at}u.washington.edu
Abstract:
Elucidation of mechanisms regulating cell cycle progressionis of fundamental importance for cell and cancer biology. Althoughseveral genes and signaling pathways are implicated in G1Sregulation, less is known regarding the mechanisms controllingcell cycle progression through G2 and M phases. We report thatextracellular signalregulated kinase 5 (ERK5), a memberof the mitogen-activated protein kinases, is activated at G2Mand required for timely mitotic entry. Stimulation of ERK5 activatednuclear factor B (NFB) through ribosomal S6 kinase 2 (RSK2)-mediatedphosphorylation and degradation of IB. Furthermore, selectiveinhibition of NFB at G2M phases substantially delayedmitotic entry and inhibited transcription of G2Mspecificgenes, including cyclin B1, cyclin B2, Plk-1, and cdc25B. Moreover,inhibition of NFB at G2M diminished mitosis induced byconstitutive activation of ERK5, providing a direct link betweenERK5, NFB, and regulation of G2M progression. We concludethat a novel ERK5NFB signaling pathway plays a key rolein regulation of the G2M progression.
K. Cude and Y. Wang contributed equally to this paper.
Abbreviations used in this paper: ca, constitutive-active; dn,dominant-negative; ERK, extracellular signalregulatedkinase; HFF, human foreskin fibroblast; hSMC, human artery smoothmuscle cell; MBP, myelin basic protein; NFB, nuclear factorB; Plk, polo-like kinase; RSK, ribosomal S6 kinase; SR, superrepressor; wt, wild-type.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Nancy R. Gough (1 May 2007) Sci. STKE2007 (384), tw151.
[DOI: 10.1126/stke.3842007tw151] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Targeted Deletion of ERK5 MAP Kinase in the Developing Nervous System Impairs Development of GABAergic Interneurons in the Main Olfactory Bulb and Behavioral Discrimination between Structurally Similar Odorants.
J. Zou, Y.-W. Pan, Z. Wang, S.-Y. Chang, W. Wang, X. Wang, C. Tournier, D. R. Storm, and Z. Xia (2012)
J. Neurosci.
32, 4118-4132
|Abstract »|Full Text »|PDF »
Targeting the BMK1 MAP Kinase Pathway in Cancer Therapy.
Macrophage Wnt7b is critical for kidney repair and regeneration.
S.-L. Lin, B. Li, S. Rao, E.-J. Yeo, T. E. Hudson, B. T. Nowlin, H. Pei, L. Chen, J. J. Zheng, T. J. Carroll, et al. (2010)
PNAS
107, 4194-4199
|Abstract »|Full Text »|PDF »
ERK5 Activity Is Required for Nerve Growth Factor-induced Neurite Outgrowth and Stabilization of Tyrosine Hydroxylase in PC12 Cells.
Y. Obara, A. Yamauchi, S. Takehara, W. Nemoto, M. Takahashi, P. J. S. Stork, and N. Nakahata (2009)
J. Biol. Chem.
284, 23564-23573
|Abstract »|Full Text »|PDF »
Myocardin inhibits cellular proliferation by inhibiting NF-{kappa}B(p65)-dependent cell cycle progression.
R.-h. Tang, X.-L. Zheng, T. E. Callis, W. E. Stansfield, J. He, A. S. Baldwin, D.-Z. Wang, and C. H. Selzman (2008)
PNAS
105, 3362-3367
|Abstract »|Full Text »|PDF »